(Q53302883)

13 May 2018

reason for preferred rank

title

Cell‐cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells (English)

1 reference

5 July 2024

Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20812223

5 July 2024

1 reference

Olga Zolochevska

1

1 reference

13 May 2018

Marxa L. Figueiredo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20812223

5 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20812223

5 July 2024

publication date

1 September 2010

1 reference

13 May 2018

1 March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20812223

full work available at URL

5 July 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.21249

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.21249

5 July 2024

1 reference

5 July 2024

1 reference

13 May 2018

volume

71

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

353-367

1 reference

13 May 2018

Endocrine therapy for prostate cancer: recent developments and current status

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Imagable 4T1 model for the study of late stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Deleted in oral cancer-1 expression upregulates proapoptosis elements in microsatellite-unstable human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

p12(DOC-1), a growth suppressor, associates with DNA polymerase alpha/primase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

doc-1--mediated apoptosis in malignant hamster oral keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Apoptosis, proliferation and p12(doc-1) profiles in normal, dysplastic and malignant squamous epithelium of the Syrian hamster cheek pouch model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

A transient three-plasmid expression system for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

The role of PTEN in prostate cancer cell tropism to the bone micro-environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5'-monophosphate dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

CDK inhibitors: cell cycle arrest versus apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Molecular and cellular effects of cis-9, trans-11-conjugated linoleic acid in enterocytes: effects on proliferation, differentiation, and gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Osteoblastic responses to TGF-beta during bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Role of Wnts in prostate cancer bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteob

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21249

DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

21 January 2018

2

1 reference

Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease

5 July 2024

18

1 reference

A third-generation lentivirus vector with a conditional packaging system

5 July 2024

19

1 reference

An in vivo model of prostate carcinoma growth and invasion in bone

5 July 2024

27

1 reference

5 July 2024

Identifiers

DOI

10.1002/PROS.21249

1 reference

13 May 2018

1 reference

13 May 2018